• 대한한방내과학회지
• /
• 제22권3호
• /
• pp.383-391
• /
• 2001

목적 : 본 연구는 목향순기탕(木香順氣湯)이 인간의 장관상피세포 계열인 Caco-2 세포에서 항산화작용을 증진시키는 효과가 있는지 검증하기 위한 실험이다. 방법 : 배양된 인간장관 세포계열인 Caco-2 세포에서 세포의 사망은 trypan blue의 소실정도에 의해 평가했으며 $H_2O_2$는 표본산화제로 사용되었다. 결과 : $H_2O_2$에서 노출된 세포들은 용량에 비례하여 세포 사망하는 결과를 보였다. 목향순기탕(木香順氣湯)은 $H_2O_2$에 의해 유발된 세포사망을 방지하였고, 0.05-1%의 농도범위에 걸쳐서 효과가 극대화되었다. 목향순기탕(木香順氣湯)과 강력한 항산화제인 DPPD는 $H_2O_2$에 의해 억제된 SOD의 활성에는 영향을 주지는 못했다. 그러나 $H_2O_2$에 의해 유발된 catalase, glutathione peroxidase, hydroperoxide 탈취효소의 활성이 감소되는 것을 억제하였다. 또한 $H_2O_2$에 의해 유발된 glutathione의 감소는 목향순기탕(木香順氣湯)과 DPPD에 의해 억제되었다. 목향순기탕(木香順氣湯)은 $H_2O_2$에 의해 유발된 ATP의 소실을 회복시켰지만 DPPD는 ATP 소실을 회복시키지 못하였다. 결론 : 이러한 결과로 볼 때 Caco-2세포에서 목향순기탕이 세포사망을 억제하는 것은 다른 기전을 통하여 항산화작용을 하는 것으로 볼 수 있다. 따라서 본 연구는 목향순기탕(木香順氣湯)이 반응성산소기에 의해 유발된 인체 위장관질환의 치료에 사용할 수 있을 가능성을 제시하고 있다.

• Journal of Nutrition and Health
• /
• 제35권4호
• /
• pp.446-453
• /
• 2002

본 논문에서는 자혈양근탕 (滋血養筋湯, JH) 및 양혈장 근건보환 (養血壯筋健步丸, YH) 처방제가 장내 칼슘흡수에 미치는 영향을 살펴보고자 인체 소장상피세포주 모델인 Caco-2 세포를 이용하여 칼슘 uptake와 net transport를 각기 평가하였으며. 그 결과를 요약하면 다음과 같다. 첫째, Caco-2 세포를 분주 후 4, 8, 16. 그리고 24일간 배양하면서 칼슘 uptake 활성을 측정 한 결과 분화가 진행될수록 uptake 활성이 증가하였다. 둘째. Caco-2 세포에 한약처방제를 50 $\mu\textrm{g}$/ml 농도로 일정시간 동안 전처리하여 칼슘 uptake 활성을 측정한 결과, YH 처방제는 24시간 전처리 시 (29.9% 증가), 그리고 JH처방제는 6시간 전처리 시 (23.9%증가) 한약처방으로 전처리하지 않은 대조세포에 비해 칼슘 uptake가 유의적으로 증가하였다. 셋째. 한약처방의 농도를 달리하면서 6시간 동안 전처리한 후 칼슘 Uptake활성을 측정한 결과, 대조세포에 비해 YH 또는 JH 처방제는 100 $\mu\textrm{g}$/ml (23% 증가) 및 50 $\mu\textrm{g}$/ml 농도 (28.3% 증가)에서 칼슘 uptake 활성을 각기 최대로 증가시켰다. 넷째, YH 또는 JH 처방제가 Caco-2 세포에 의한 칼슘 net transport에 미치는 영향을 평가하기 위해 5, 50, 100 $\mu\textrm{g}$/ml농도의 한약처방제로 6시간동안 Caco-2세포에 전처리한 결과, 두가지 한약처방제 모두 칼슘 net transport에 유의적인 변화를 초래하지 않았다. 이상의 in vitro연구결과는 양혈 및 양근작용에 관여하는 자혈양근탕 및 양혈장근건보환 처방제가 소장상피세포를 통한 칼슘 uptake 활성은 증가시킨 한편 칼슘 net transport 활성에 변화를 초래하지 않았고. 결과적으로 장내 칼슘 흡수에 유의적인 영향을 미치지 않았음을 제시하는 것이다

• 한국미생물·생명공학회지
• /
• 제36권2호
• /
• pp.121-127
• /
• 2008

IDCC 9203은 모유 영양아의 분변으로부터 분리하였으며 분자생물학적 동정 결과 Lactobacillus johnsonii로 밝혀졌다. L. johnsonii IDCC 9203은 pH 2.3으로 조정된 MRS 액체배지에서 2시간 반응시 81%의 생존율을 보였으며, 0.3% bile이 함유된 MRS 액체배지에서는 5시간 반응시 57%의 생존율을 보여 산과 담즙에 대한 내성이 있는 것으로 나타났다. L. johnsonii IDCC 9203은 in vitro에서 Caco-2 cells에 대한 부착능이 우수하여 S. typhimurium KCTC 2054의 부착을 경쟁적으로 50%이상 감소시켰다 또한 in vivo에서 L. johnsonii IDCC 9203은 항생제로 교란된 mice의 장내에 정착하여 증식하였으며 이상 증식된 salmonella ($10^9CFU/g$ feces)를 초기 수준 ($(10^5CFU/g$ feces)로 감소시켰다. 이상의 결과에서 L. johnsonii IDCC 9203은 사람 및 동물에 유용한 프로바이오틱 특성을 가지고 있어 정장용 유산균으로 개발될 수 있을 것으로 기대된다.

• 대한약학회:학술대회논문집
• /
• 대한약학회 2001년도 Proceedings of International Convention of the Pharmaceutical Society of Korea
• /
• pp.225.2-225.2
• /
• 2001

• Biomolecules & Therapeutics
• /
• 제15권2호
• /
• pp.102-107
• /
• 2007

Cimetidine, a substrate for P-glycoprotein (P-gp), is a well known drug interacting with a variety of drugs and results in alteration of pharmacokinetic parameters by concomitant administration. The aim of present study was to investigate whether cimetidine affects the transport of various quinolone antibiotics in human colorectal cancer cell line (Caco-2) system which has been typically used to investigate drug transport via P-gp. The apparent permeability coefficients (P$_{app}$) value of 9 quinolone antibiotics in the co-treatment with cimetidine was examined. Apical to basolateral (AP-to-BL) transport of fleroxacin in the co-treatment with cimetidine was increased to 1.5-fold (p<0.01) compared with that of fleroxacin alone, whereas basolateral to apical (BL-to-AP) transport of fleroxacin was decreased to 0.83-fold significantly (p<0.05). Ofloxacin was decreased to 0.8-fold (p<0.01) and 0.72-fold (p<0.01) significantly in AP-to-BL and BL-to-AP direction, respectively by cimetidine cotreatment. The P$_{app}$ values of gatifloxacin, moxifloxacin, ciprofloxacin and rufloxacin also were changed by cimetidine. These results have a potential that cimetidine influences on the pharmacokinetics of quinolone antibiotics. It suggests that careful drug monitoring and dosage adjustment may be necessary during the co-administration of quinolone antibiotics with cimetidine.

• Journal of Pharmaceutical Investigation
• /
• 제36권4호
• /
• pp.263-269
• /
• 2006

Deficiencies in the early ADMET(absorption, distribution, metabolism, elimination and toxicity) information on drug candidate extract a significant economic penalty on pharmaceutical firms. Microscale cell culture analogue-microscale gastrointestinal(${\mu}CCA-{\mu}GI$) device using Caco 2, L2 and HEp G2/C3A cells, which mimic metabolic process after absorption occurring in humans was used to investigate the toxicity of the model chemical, acetaminophen(AAP). The toxicity of acetaminophen determined after induction of CYP 1A1/2 in Caco 2 cells was not significant. In a coculture system, although no significant reduction in viability of HEp G2/C3A and L2 cells was found, approximately 5 fold increase in the CYP 1A1/2 activity was observed. These results appear to be related to organ-organ interaction. The oral administration of a drug requires addition of the absorption process through small intestine to the current ${\mu}CCA$ device. Therefore, a perfusion coculture system was employed for the evaluation of the absolution across the small intestine and resulting toxicity in the liver and lung. This system give comprehensive and physiologic information on oral uptake and resulting toxicity as in the body. The current ${\mu}CCA$ device can be used to demonstrate the toxic effect due to organ to organ interaction after oral administration,

• 대한약학회:학술대회논문집
• /
• 대한약학회 2001년도 Proceedings of International Convention of the Pharmaceutical Society of Korea
• /
• pp.300.2-301
• /
• 2001

• 한국미생물생명공학회:학술대회논문집
• /
• 한국미생물생명공학회 2003년도 2003 Annual Meeting, BioExhibition and International Symposium
• /
• pp.129-131
• /
• 2003

Recombinant bioluminescent bacteria and cultured human cells were applied for toxicogenomic analysis of environmentally hazardous chemicals. Recombinant bioluminescent biosensing cells were used to detect and classify the toxicity caused by various chemicals. Classification of toxicity was realized based upon the chemicals' mode of action using DNA-, oxidative-, protein, and membrane-damage sensitive strains. As well, a simple double-layered cell culture system using Caco-2 cells and Hep G2 cells, which mimic the metabolic processes occurring in humans, such as adsorption through the small intestine and biotransformationin both the small intestine and the liver, was developed to investigate the toxicity of hazardous materials to humans. For a more in-depth analysis, a DNA microarray was used to study the transcriptional responses of Caco-2 and Hep G2 cells to benzo〔a〕pyrene.

• 대한한의학회지
• /
• 제25권4호
• /
• pp.61-78
• /
• 2004

Objective : This study was undertaken to determine whether Gamibaegi-eum (BGU) in vitro and in vivo exerts a beneficial effect against cell injury induced by reactive oxygen species (ROS) in the human intestine. Methods : Effects of BGU in vitro on cell injury were examined using Caco-2 cells, cultured human intestinal cell line. Exposure of cells to H₂O₂ induced increases in the loss of cell viability in a time and dose-dependent fashion. Results : BGU prevented H₂O₂-induced cell death and its effect was dose-dependent over a concentration range of 0.05­1%. H₂O₂-induced cell death was prevented by catalase, the hydrogen peroxide scavenger enzyme, and deferoxamine, the iron chelator. However, the potent antioxidant DPPD did not affect H₂O₂-induced cell death. H₂O₂ increased lipid peroxidation, which was inhibited by BGU and DPPD. H₂O₂ caused DNA damage in a dose-dependent manner, which was prevented by BGU, catalase, and deferoxamine, but not DPPD. BGU restored ATP depletion induced by H₂O₂. BGU inhibited generation of superoxide and H₂O₂ and scavenged directly H₂O₂. Oral administration of mepirizole in vivo at a dose of 200mg/kg resulted in ulcer lesions in the stomach and the proximal duodenum. Pretreatment of BGU(0.1%/kg, orally) and catalase (800Units/kg, i.v.) significantly decreased the size of ulcers. Mepirizole increased lipid peroxidation in the mucosa of the duodenum, suggesting an involvement of ROS. Pretreatment of BGU and catalase significantly inhibited lipid peroxidation induced by mepirizole. Morphological studies showed that mepirizole treatment causes duodenal injury and its effect is prevented by BGU. Conclusion : These results indicate that BGU exerts a protective effect against cell injury in vitro and in vivo through antioxidant action. The present study suggests that BGU may playa therapeutic role in the treatment of human gastrointestinal diseases mediated by ROS.

• Asian Pacific Journal of Cancer Prevention
• /
• 제17권11호
• /
• pp.4929-4934
• /
• 2016

Cancer, a worldwide epidemic disease with diverse origins, involves abnormal cell growth with the potential to invade other parts of the body. Globally, it is the main cause of mortality and morbidity. To overcome the drawbacks of the commercially available chemotherapies, natural products-loaded nano-composites are recommended to improve cancer targetability and decrease the harmful impact on normal cells. This study aimed at exploring the anti-cancer impacts of Moringa oleifera seed oil in its free- (MO) and nano-formulations (MOn) through studying whether it mechanistically promotes mitochondrial apoptosis-mediating cell death. Mitochondrial-based cytotoxicity and flow cytometric-based apoptosis analyses were performed on cancer HepG2, MCF7, HCT 116, and Caco-2 cell lines against normal kidney BHK-21 cell line. The present study resulted that MOn triggered colorectal cancer Caco-2 and HCT 116 cytotoxicity via mitochondrial dysfunction more powerful than its free counterpart (MO). On the other side, MOn and MO remarkably induces HCT 116 mitochondrial apoptosis, while sparing normal BHK-21 cells with minimal cytotoxic effect. The present results concluded that nano-micelle of Moringa oleifera seed oil (MOn) can provide a novel therapeutic approach for colorectal and breast cancers via mitochondrial-mediated apoptosis, while sparing normal and even liver cancer cells a bit healthy or with minimal harmful effect. Intriguingly, MOn induced breast cancer not hepatocellular carcinoma cell death.